Profil
Actuellement, William Mezzanotte est Chief Medical Officer, EVP & Head-R&D chez CSL Ltd. Le Dr Mezzanotte siège également au conseil d'administration de BELLUS Health, Inc. et du University City Science Center. Auparavant, le Dr Mezzanotte était vice-président et chef des services respiratoires et de l'inflammation chez AstraZeneca Plc et premier vice-président et chef du domaine thérapeutique chez C.H. Boehringer Sohn AG & Co. KG. William Mezzanotte a obtenu un diplôme de premier cycle de l'université de Villanova, un doctorat de l'université de Pennsylvanie et un diplôme d'études supérieures de l'université Johns Hopkins.
Postes actifs de William Mezzanotte
| Sociétés | Poste | Début |
|---|---|---|
| CSL LIMITED | Directeur Technique/Scientifique/R&D | 01/04/2017 |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Directeur/Membre du Conseil | 19/06/2020 |
Anciens postes connus de William Mezzanotte
| Sociétés | Poste | Fin |
|---|---|---|
| BELLUS HEALTH | Directeur/Membre du Conseil | 01/01/2023 |
Boehringer Ingelheim Pty Ltd.
Boehringer Ingelheim Pty Ltd. Pharmaceuticals: MajorHealth Technology Provides phamaceutical development | Corporate Officer/Principal | 01/04/2017 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/03/2015 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Directeur Technique/Scientifique/R&D | - |
Formation de William Mezzanotte
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
BELLUS Health, Inc.
BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Miscellaneous |
Boehringer Ingelheim Pty Ltd.
Boehringer Ingelheim Pty Ltd. Pharmaceuticals: MajorHealth Technology Provides phamaceutical development | Health Technology |
















